Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Selective inhibition of NF-κB activation by peptides designed to disrupt nemo oligomerization

Selective inhibition of NF-κB activation by peptides designed to disrupt nemo oligomerization

US Patent 7700553 · Granted Apr 20, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for selecting a sound processing delay scheme for a hearing 2024
Stapled peptide inhibitors of nemo as potential anti-inflammatory and anti-cance2024
Stapled peptide inhibitors of nemo as potential anti-inflammatory and anti-cance2024
Stapled peptide inhibitors of nemo as potential anti-inflammatory and anti-cance2024
Polyclonal antibodies specific for serogroup X of N. meningitidis and uses there2023
Determining social interaction of a user wearing a hearing device2023
Peptidomimetics, method of synthesis and uses thereof2022
Peptidomimetics, method of synthesis and uses thereof2022
Hearing device with multiple delay paths2022
Hearing devices and methods for implementing an adaptively adjusted cut-off freq2021
Stapled peptide inhibitors of NEMO as potential anti-inflammatory and anti-cance2021
Stapled peptide inhibitors of NEMO as potential anti-inflammatory and anti-cance2021